Narrowband UVB Phototherapy Treatment: Safe, Effective, & Versatile
Phothera is the leading manufacturer of FDA-cleared home and clinical use narrowband phototherapy devices for chronic skin conditions. The company was formed through the merger of Daavlin and National Biological Corporation (NatBio), both unified under Madison Industries — a global industrial leader dedicated to building brands that are safer, healthier, and built for long-term growth. Phothera brings over 80 years of combined phototherapy experience.
Bring Proven Phototherapy into Modern Dermatology Workflows
Dermatologists have relied on narrowband ultraviolet B (NB-UVB) phototherapy for decades to treat psoriasis, vitiligo, and cutaneous T-cell lymphoma (CTCL), where it remains a first-line therapy in the American Academy of Dermatology (AAD) guidelines. For atopic dermatitis (eczema), phototherapy is an important option when topical treatments are not enough.
Phothera helps make prescribing and managing phototherapy simple with tools, like convenient EMR integrations and digital prescription submissions, designed to support you, your practice, and your patients.
Why Dermatologists Choose NB-UVB Phototherapy with Phothera
Reduce reliance on systemic medications:
A medication-free treatment option for psoriasis, vitiligo, CTCL, and atopic dermatitis.
Improved adherence with home phototherapy:
Guided Mode devices include protocols with built-in safety guardrails and demonstrated 3x higher adherence in the 783-patient LITE clinical trial.1
Simplify prescribing and workflow:
Compatible with Epic and EMA to support prescribing and documentation.
Expand patient access:
Broad insurance coverage with $0 cost for eligible patients, helping remove financial barriers to treatment.
Phototherapy can be administered in-office or at-home, making it a versatile & widely adaptable treatment choice.
At-Home Phototherapy
- Designed for safe home treatment
- Guided Mode technology with on-device app and safety protocols built in
- 3x higher adherence compared with standard home therapy (LITE Study, n=783)1
- Broad insurance coverage with $0 cost for eligible patients*
- EMR-compatible prescribing with EMA®, Epic®, and most other major dermtology EMRs
*$0 patient cost applies to eligible insured patients. Not all patients will qualify.
In-Office Phototherapy
- Clinical phototherapy devices designed for dermatology practices
- Also covered by most major insurance providers
- Expand treatment offerings within your practice
- Recommended in national dermatology treatment guidelines
The same proven Narrowband UVB therapy your patients trust–delivered where it works best for your patient.
The Prescribing Process Made Easy
Step 1
Write a prescription for home phototherapy (NBUVB) and specify the indication.
Step 2
Submit via EMA®, Epic®, or the Phothera E-Form — choose the method that works best for your practice.
Step 3
Phothera Cares handles prior authorization, claims, and appeals to support broader patient access.
Step 4
Eligible insured patients pay as little as $0*.
Step 5
Device shipped, free of charge, directly to the patient’s home.
Working with Phothera just got faster. As part of our ongoing commitment to our prescribers, we have launched a new provider line for everything Phothera.
1-844-676-2882 (1-844-67-NBUVB)
- Orders, prior authorization, and shipping status
- Refills and treatment unlocks
- Insurance, coverage, and billing
- Device technical support
- Prescription forms and documentation
- Dosing questions and clinical guidance
- Account setup and operations
I was fortunate to have a dermatologist that noticed the treatments in his office were transformative for me. He didn’t hesitate to order a light therapy box for my home & I have been so happy to be in charge of my own treatments.
– Gordon (phototherapy patient)
The 5-in-1 Benefits of Narrowband Phototherapy
UNRIVALED SAFETY PROFILE
Narrowband UVB phototherapy is an ideal first line treatment that is safe for pediatrics2, pregnant women3, geriatics4, and immunocompromised patients5 and needle-adverse.
Phototherapy’s minimal side effect profile makes it a safer alternative to many systemic medications.
Research has also shown that Narrowband UVB phototherapy has no significant association with Malignant Melanoma.
INDUSTRY LEADING EFFECTIVENESS
For decades, clinical study data has shown consistently high rates of clearance (95.1% clearance5) for both PUVA and Narrowband UVB phototherapy, with many patients reaching PASI 75 weeks earlier than the leading biologics.5
CUSTOMIZABLE TREATMENT OPTIONS
Phothera technology makes customizing treatments for home, in-office, or dual-path treatments easy and intuitive with technologically driven solutions that keep the provider in control and connected to their patients.
EXPAND PATIENT POPULATION
In-office phototherapy is highly accessible for any size of practice and allows a practice to provide a treatment that is safe, effective, and highly viable for the majority of patients living with chronic skin conditions.
Treating just three patients, three times per week ensures consistent utilization of in-office equipment.
COST EFFECTIVENESS FOR PATIENTS
Phothera Cares patient access program removes cost as a patient objection, with eligible patients paying as little as $0 out of pocket.* Phothera manages prior authorization, claims submissions, and appeals on behalf of the prescribing provider.
*$0 patient cost applies to eligible insured patients. Not all patients will qualify.
Enhance patient care & grow your practice
Phototherapy has the unique ability to expand a provider’s patient population by attracting individuals with chronic skin conditions seeking effective and safe treatments. Its versatility allows for both in-office sessions and home use options, accommodating diverse lifestyles and preferences. By integrating phototherapy, providers can meet the growing demand for innovative therapeutic skincare solutions with a highly effective treatment strategy for patients making it a valuable opportunity for clinics everywhere.
I am a firm believer that phototherapy is key to the success of any dermatological practice as it provides a safe & effective treatment solution for a variety of chronic skin conditions.
– Dr. David B Vasily, M.D.
Learn how Phothera can help you.
REFERENCES:
- Gelfand JM et al., JAMA Dermatol. 2024; doi:10.1001/jamadermatol.2024.3897
- Jury CS, McHenry P, Burden AD, Lever R, Bilsland D. Narrowband ultraviolet B (UVB) phototherapy in children. Clin Exp Dermatol. 2006 Mar;31(2):196-9. doi: 10.1111/j.1365-2230.2006.02061.x. PMID: 16487089.
- Myers E, Kheradmand S, Miller R. An Update on Narrowband Ultraviolet B Therapy for the Treatment of Skin Diseases. Cureus. 2021 Nov 1;13(11):e19182. doi: 10.7759/cureus.19182. PMID: 34873522; PMCID: PMC8634827.
- Bulur, I., Erdogan, H. K., Aksu, A. E., Karapınar, T., & Saracoglu, Z. N. (2018). The efficacy and safety of phototherapy in geriatric patients: a retrospective study. Anais brasileiros de dermatologia, 93(1), 33–38. https://doi.org/10.1590/abd1806-4841.20185468.
- Rácz, E., & Prens, E. P. (2017). Phototherapy of psoriasis, a chronic inflammatory skin disease. Advances in Experimental Medicine and Biology, 287–294. https://doi.org/10.1007/978-3-319-56017-5_24.